FDA approval of a generic venetoclax formulation; regulatory action confirming bioequivalence and manufacturing standards, not a clinical efficacy trial.
Reported
Approval date2026-05-15
Formulations approved10 mg, 50 mg, 100 mg tablets
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of a generic venetoclax formulation; regulatory action confirming bioequivalence and manufacturing standards, not a clinical efficacy trial.